Mylan Nixes Teva's $40B Takeover Bid Amid Pharma Tussle
Generic drugmaker Mylan N.V. formally rejected a hostile takeover by rival Teva Pharmaceuticals Industries Ltd. on Monday, escalating a three-way tussle just days after its own unsolicited bid for Irish over-the-counter...To view the full article, register now.
Already a subscriber? Click here to view full article